061 Metabolic alteration in hypertrophic cardiomyopathy (METAL-HCM Study): randomised double blinded placebo controlled trial of perhexiline therapy in patient with hypertrophic cardiomyopathy
K Abozguia, P Elliott, W McKenna, TT Phan, G Nallur-Shivu, I Ahmed, AR Maher, H Ashrafian, H Watkins, MP Frenneaux
Heart Jun 2010, 96 (Suppl 1) A36; DOI: 10.1136/hrt.2010.195966.9